-
1Academic Journal
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
2Academic Journal
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
3Image
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
4Image
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
5Image
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
6Image
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
7Image
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
8
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
9
المؤلفون: Kazuto Nakae (11559141), Sho Masui (11559144), Atsushi Yonezawa (784929), Motomu Hashimoto (388292), Ryu Watanabe (4025591), Koichi Murata (164555), Kosaku Murakami (198978), Masao Tanaka (107633), Hiromu Ito (164599), Kotoko Yokoyama (11559147), Noriko Iwamoto (2073397), Takashi Shimada (234606), Miyuki Nakamura (8159133), Masaya Denda (3323322), Kotaro Itohara (11559150), Shunsaku Nakagawa (430323), Yasuaki Ikemi (3615404), Satoshi Imai (124356), Takayuki Nakagawa (202988), Makoto Hayakari (3134937), Kazuo Matsubara (647154)
مصطلحات موضوعية: Biochemistry, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Science Policy, Hematology, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified,
+infliximab%22">xlink "> infliximab, tandem mass spectrometer, maximum effect point, japanese cohort database, although previous studies, better therapeutic response, serum ifx levels, high ifx groups, high ifx group, rheumatoid arthritis management, 32 956, 311 ra patients, ifx measurement point, retrospective study based, low ifx group, rheumatoid arthritis, ra ), patients still, ml based -
10Image
المؤلفون: Tomohiro Omura (784928), Luna Nomura (11815739), Ran Watanabe (11815742), Hiroki Nishiguchi (11815745), Kazuhiro Yamamoto (115929), Satoshi Imai (124356), Shunsaku Nakagawa (430323), Kotaro Itohara (11559150), Atsushi Yonezawa (784929), Takayuki Nakagawa (202988), Junichi Kunimasa (11815748), Ikuko Yano (784930), Kazuo Matsubara (647154)